跳至主要内容
临床试验/NCT00761085
NCT00761085已完成不适用

Methadone in Pediatric and Adult Sickle Cell Patients

Washington University School of Medicine1 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2008年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
47
试验地点
1
主要终点
To Determine the Pharmacokinetics of Methadone in Children and Adults With Sickle Cell Disease Experiencing a VOE.

研究概览

简要总结

To determine the pharmacokinetics of methadone in children and adults with SCD who are experiencing a painful episode.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
7 Years 至 40 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Greater than or equal to 7 years and less than or equal to 40 years
  • Confirmed diagnosis of any form of sickle cell disease, including sickle cell anemia, sickle-hemoglobin C disease, and sickle-B thalassemia
  • Currently experiencing a vaso-occlusive episode (VOE), defined as acute pain in the extremities
  • Admitted to the inpatient unit for further treatment
  • Started on morphine patient controlled analgesia and infusion for pain management

排除标准

  • Diagnosis of acute chest syndrome
  • New focal neurologic findings or clinical concern of stroke
  • Aplastic crisis with hemoglobin 2 g/dl below steady-state value
  • Allergy to morphine or methadone
  • Any other medical condition that the attending physician deems to be a contraindication to therapy
  • Liver or renal insufficiency or failure, and congestive heart failure

研究组 & 干预措施

Methadone-Children

Active Comparator

Methadone comparison to standard of care for pain management

干预措施: Methadone (Drug)

Morphine-Children

Active Comparator

Morphine standard of Care pain management

干预措施: Morphine (Drug)

Methadone-Adults

Active Comparator

Methadone comparison to standard of care for pain management

干预措施: Methadone (Drug)

Morphine-Adults

Active Comparator

Morphine standard of Care pain management

干预措施: Morphine (Drug)

结局指标

主要结局

To Determine the Pharmacokinetics of Methadone in Children and Adults With Sickle Cell Disease Experiencing a VOE.

时间窗: 96 hr

R-Methadone AUC

次要结局

  • Pain Relief(72 hr)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验